RSS feed: news [?]

Home » News » Midatech, MonoSol Rx file US patent app for nano delivery

Midatech and MonoSol Rx have filed a provisional US patent application covering a nanoparticle film drug delivery system for administering biologics. 

Use of the film could allow biologics currently delivered by injection to be administered buccally or sublingually. Eliminating the need for regular injections would make treatments more convenient for patients. 

Furthermore, the film could improve delivery of certain molecules that are administered orally. Administration using the film would allow therapeutics to enter the bloodstream without exposure to the gastrointestinal tract, avoiding side-effects which can be associated with this interaction. 

Tom Rademacher, chairman of Midatech, said: “The system has the potential to solve many of the problems associated with the effective delivery of biologics, and we are very pleased to be continuing our collaboration with Monosol Rx.” 

Midatech and MonoSol Rx began collaborating in 2008. This collaboration has combined the nanoparticle expertise at Midatech with the PharmFilm technology developed by MonoSol Rx.

All rights reserved. No information from the web site may be reproduced without the permission of the magazine's editorial board.

© Eurasian chemical market, 2005-2012